Get started
Work

Outcomes after Second Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies

Year: 2017
Type: article
Abstract: Allogeneic hematopoietic cell transplantation (HCT) can produce long term disease free survival for many patients with hematologic malignancies but treatment options are limited for patients that relapse post-transplant. A second HCT (HCT2) can be performed, but at the cost of significant mortality. Data on patient outcomes after a HCT2 are limited.
DOI: 10.1016/j.bbmt.2016.12.185
Authors: Eric Huselton, Michael Slade, Camille Abboud, Amanda Cashen, John F. DiPersio, Armin Ghobadi, Iskra Pusic, Rizwan Romee, Geoffrey L. Uy, Ravi Vij, Peter Westervelt, Mark A. Schroeder
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2590172491
FWCI:
Cites:
Cited by:
Related to: 10